N-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide

C144H184F6N20O18S3 — CID 163625353

IUPACN-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide
SMILESCC(C)CCS(=O)(=O)N[C@@H](CC(=O)N1CCC[C@@H]1c1ccccc1)C(=O)CC(C)c1nc2ccccc2[nH]1.CC(C)CCS(=O)(=O)N[C@@H](CC(=O)N1CCC[C@@H]1c1ccccc1)C(=O)C[C@@H](C)c1nc2ccccc2[nH]1.CC(C)CCS(=O)(=O)N[C@@H](CC(=O)N1CCC[C@@H]1c1ccccc1)C(=O)C[C@H](C)c1nc2ccccc2[nH]1.C[C@H](CC(=O)[C@H](CC(=O)N1CCCC1C1CC1)NC(=O)C1CC2(C1)CC(F)(F)C2)c1nc2c(F)cccc2[nH]1.C[C@H](CC(=O)[C@H](CC(=O)N1CCCC[C@@H]1C)NC(=O)C1CC2(C1)CC(F)(F)C2)c1nc2c(F)cccc2[nH]1
InChIInChI=1S/C29H35F3N4O3.3C29H38N4O4S.C28H35F3N4O3/c1-16(26-33-20-5-2-4-19(30)25(20)35-26)10-23(37)21(11-24(38)36-9-3-6-22(36)17-7-8-17)34-27(39)18-12-28(13-18)14-29(31,32)15-28;3*1-20(2)15-17-38(36,37)32-25(19-28(35)33-16-9-14-26(33)22-10-5-4-6-11-22)27(34)18-21(3)29-30-23-12-7-8-13-24(23)31-29;1-16(25-32-20-8-5-7-19(29)24(20)34-25)10-22(36)21(11-23(37)35-9-4-3-6-17(35)2)33-26(38)18-12-27(13-18)14-28(30,31)15-27/h2,4-5,16-18,21-22H,3,6-15H2,1H3,(H,33,35)(H,34,39);3*4-8,10-13,20-21,25-26,32H,9,14-19H2,1-3H3,(H,30,31);5,7-8,16-18,21H,3-4,6,9-15H2,1-2H3,(H,32,34)(H,33,38)/t16-,21+,22?;21?,25-,26+;21-,25+,26-;21-,25-,26+;16-,17+,21+/m10101/s1
InChIKeyHRNQRAAKORRRQT-FETYVJPBSA-N
MW2693.37 g/mol
LogP23.87
Rot. Bonds53

About N-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide

N-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide (PubChem CID 163625353) has the molecular formula C144H184F6N20O18S3 and a molecular weight of 2693.37 g/mol. Its IUPAC name is N-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide.

Molecular Properties

Compound NameN-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide
PubChem CID163625353
Molecular FormulaC144H184F6N20O18S3
Molecular Weight2693.37 g/mol
Exact Mass2691.32
IUPAC NameN-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide
SMILESCC(C)CCS(=O)(=O)N[C@@H](CC(=O)N1CCC[C@@H]1c1ccccc1)C(=O)CC(C)c1nc2ccccc2[nH]1.CC(C)CCS(=O)(=O)N[C@@H](CC(=O)N1CCC[C@@H]1c1ccccc1)C(=O)C[C@@H](C)c1nc2ccccc2[nH]1.CC(C)CCS(=O)(=O)N[C@@H](CC(=O)N1CCC[C@@H]1c1ccccc1)C(=O)C[C@H](C)c1nc2ccccc2[nH]1.C[C@H](CC(=O)[C@H](CC(=O)N1CCCC1C1CC1)NC(=O)C1CC2(C1)CC(F)(F)C2)c1nc2c(F)cccc2[nH]1.C[C@H](CC(=O)[C@H](CC(=O)N1CCCC[C@@H]1C)NC(=O)C1CC2(C1)CC(F)(F)C2)c1nc2c(F)cccc2[nH]1
InChIInChI=1S/C29H35F3N4O3.3C29H38N4O4S.C28H35F3N4O3/c1-16(26-33-20-5-2-4-19(30)25(20)35-26)10-23(37)21(11-24(38)36-9-3-6-22(36)17-7-8-17)34-27(39)18-12-28(13-18)14-29(31,32)15-28;3*1-20(2)15-17-38(36,37)32-25(19-28(35)33-16-9-14-26(33)22-10-5-4-6-11-22)27(34)18-21(3)29-30-23-12-7-8-13-24(23)31-29;1-16(25-32-20-8-5-7-19(29)24(20)34-25)10-22(36)21(11-23(37)35-9-4-3-6-17(35)2)33-26(38)18-12-27(13-18)14-28(30,31)15-27/h2,4-5,16-18,21-22H,3,6-15H2,1H3,(H,33,35)(H,34,39);3*4-8,10-13,20-21,25-26,32H,9,14-19H2,1-3H3,(H,30,31);5,7-8,16-18,21H,3-4,6,9-15H2,1-2H3,(H,32,34)(H,33,38)/t16-,21+,22?;21?,25-,26+;21-,25+,26-;21-,25-,26+;16-,17+,21+/m10101/s1
InChIKeyHRNQRAAKORRRQT-FETYVJPBSA-N
XLogP23.87
TPSA527.01 Ų
H-Bond Donors10
H-Bond Acceptors23
Rotatable Bonds53
Heavy Atoms191
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002693.37
LogP ≤ 523.87
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1023

Analyze N-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide?
The IUPAC name of N-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide (CID 163625353) is N-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide.
What is the SMILES notation for N-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide?
The canonical SMILES for N-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide is CC(C)CCS(=O)(=O)N[C@@H](CC(=O)N1CCC[C@@H]1c1ccccc1)C(=O)CC(C)c1nc2ccccc2[nH]1.CC(C)CCS(=O)(=O)N[C@@H](CC(=O)N1CCC[C@@H]1c1ccccc1)C(=O)C[C@@H](C)c1nc2ccccc2[nH]1.CC(C)CCS(=O)(=O)N[C@@H](CC(=O)N1CCC[C@@H]1c1ccccc1)C(=O)C[C@H](C)c1nc2ccccc2[nH]1.C[C@H](CC(=O)[C@H](CC(=O)N1CCCC1C1CC1)NC(=O)C1CC2(C1)CC(F)(F)C2)c1nc2c(F)cccc2[nH]1.C[C@H](CC(=O)[C@H](CC(=O)N1CCCC[C@@H]1C)NC(=O)C1CC2(C1)CC(F)(F)C2)c1nc2c(F)cccc2[nH]1.
What is the InChIKey of N-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide?
The InChIKey is HRNQRAAKORRRQT-FETYVJPBSA-N. The full InChI is InChI=1S/C29H35F3N4O3.3C29H38N4O4S.C28H35F3N4O3/c1-16(26-33-20-5-2-4-19(30)25(20)35-26)10-23(37)21(11-24(38)36-9-3-6-22(36)17-7-8-17)34-27(39)18-12-28(13-18)14-29(31,32)15-28;3*1-20(2)15-17-38(36,37)32-25(19-28(35)33-16-9-14-26(33)22-10-5-4-6-11-22)27(34)18-21(3)29-30-23-12-7-8-13-24(23)31-29;1-16(25-32-20-8-5-7-19(29)24(20)34-25)10-22(36)21(11-23(37)35-9-4-3-6-17(35)2)33-26(38)18-12-27(13-18)14-28(30,31)15-27/h2,4-5,16-18,21-22H,3,6-15H2,1H3,(H,33,35)(H,34,39);3*4-8,10-13,20-21,25-26,32H,9,14-19H2,1-3H3,(H,30,31);5,7-8,16-18,21H,3-4,6,9-15H2,1-2H3,(H,32,34)(H,33,38)/t16-,21+,22?;21?,25-,26+;21-,25+,26-;21-,25-,26+;16-,17+,21+/m10101/s1.
What are the key properties of N-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide?
N-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide has a molecular weight of 2693.37 g/mol, XLogP of 23.87, 53 rotatable bonds, 10 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6S)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-6-(1H-benzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-3-methylbutane-1-sulfonamide;N-[(3S,6R)-1-(2-cyclopropylpyrrolidin-1-yl)-6-(4-fluoro-1H-benzimidazol-2-yl)-1,4-dioxoheptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;2,2-difluoro-N-[(3S,6R)-6-(4-fluoro-1H-benzimidazol-2-yl)-1-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxoheptan-3-yl]spiro[3.3]heptane-6-carboxamide is sourced from PubChem (CID 163625353), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).